| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8213070 | International Journal of Radiation Oncology*Biology*Physics | 2017 | 35 Pages |
Abstract
By use of standard benchmarks for cost-effectiveness in the United States, TORS may be a cost-effective alternative for the subset of patients with early-stage OPSCC but demonstrates considerable sensitivity to assumptions around quality of life.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Danielle MD, MPH, Lisa MD, MPH, Emily MPhil, PhD, Jane MSc, PhD, Stephanie MD, FRCSC, MPH, David PhD, MD, FRCPC, Alexander V. MD, FRCPC, BSc, MSc, PhD, Aaron BSc, MBBS, FRACP, Brian MB, FRCPC,